Jun Beng Kong
Clinical Oncology Society of Australia Annual Scientific Meeting 2021
Days
Monday, 15th November
Tuesday, 16th November
Wednesday, 17th November
Thursday, 18th November
Search
Speakers
Jun Beng Kong
I am a medical oncologist based in regional Australia with an interest in clinical trials and healthcare equity.
Abstracts this author is presenting:
Quantifying the benefit of the addition of pertuzumab to standard neoadjuvant chemotherapy plus trastuzumab for HER 2 positive breast cancer – the experience of a single oncology unit
—
e-Poster Listing
